In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...

Despite its importance in drug development, dissolution testing still has some limitations, but advances in automation and real-time monitoring are producing promising results. The importance and ...

The Gilson 241 Automated Double Dissolution System (ADDS) was developed with a Major Pharmaceutical company to address the growing need for increased dissolution testing by HPLC. The system controls ...

Numerous therapeutic advantages are offered by sustained-release drugs, which release active pharmaceutical ingredients (APIs) in a gradual manner. However, the QC of such drugs through conventional ...